tradingkey.logo
tradingkey.logo
Search

Niagen Bioscience Inc

NAGE
Add to Watchlist
3.400USD
+0.080+2.41%
Close 07-31 16:00ETQuotes delayed by 15 min
270.79MMarket Cap
14.56P/E TTM

Niagen Bioscience Inc

3.400
+0.080+2.41%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+2.41%

5 Days

+5.92%

1 Month

+2.10%

6 Months

-43.24%

Year to Date

-46.54%

1 Year

-62.39%

Key Figures
3.320Open
3.410High
648.54KVolume
14.56P/E TTM
12.06P/E Dynamic
--Dividend TTM
0.82%Turnover Ratio
3.320Prev. Close
3.210Low
1.48MTurnover
31.60P/E Static
3.28P/B
0.00%Div Yield TTM
19.05%ROA
14.69052wk High
1.09Volume Ratio
8.55MNet Profit
79.46MShares
0.2335EPS TTM
2.19Beta
27.07%ROE
4.16052wk Low
6.02%Amplitude
63.47%Gross Margin
270.79MMarket Cap
-1.71Reward/Risk
3.01%Risk Rate

Key Insights

Niagen Bioscience Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 78 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.42.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Niagen Bioscience Inc's Score

Industry at a Glance

Industry Ranking
78 / 385
Overall Ranking
154 / 4281
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Niagen Bioscience Inc Highlights

StrengthsRisks
Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 54.87% year-on-year.
Fairly Valued
The company’s latest PE is 14.56, at a medium 3-year percentile range.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 9.36K shares of this stock.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
12.417
Target Price
+265.20%
Upside Space

Niagen Bioscience Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 6 analysts
Buy
Current Rating
12.417
Target Price
+265.20%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Niagen Bioscience Inc
NAGE
6
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99

Indicators

Indicators
Sell(1)
Neutral(3)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
0.023
Neutral
RSI(14)
50.777
Neutral
STOCH(KDJ)(9,3,3)
57.973
Buy
ATR(14)
0.159
Low Volatility
CCI(14)
17.666
Neutral
Williams %R
31.325
Buy
TRIX(12,20)
-0.211
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
3.292
Buy
MA10
3.311
Buy
MA20
3.361
Buy
MA50
3.452
Sell
MA100
3.999
Sell
MA200
5.168
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Niagen Bioscience Inc Info

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
Ticker SymbolNAGE
CompanyNiagen Bioscience Inc
CEOFried (Robert N)
Websitehttps://www.niagenbioscience.com/

Shareholders

Shareholders
Shareholders
Proportion
Brilliant Dynasty Ltd
14.32%
Pioneer Step Holdings, Ltd.
8.69%
BlackRock Institutional Trust Company, N.A.
4.43%
SteelPeak Wealth, LLC
4.24%
Vanguard Capital Management, LLC
2.70%
Other
65.62%

FAQs

What is the current price of Niagen Bioscience Inc (NAGE)?

The current price of Niagen Bioscience Inc (NAGE) is 3.40.

What is the symbol of Niagen Bioscience Inc?

The ticker symbol of Niagen Bioscience Inc is NAGE.

What is the 52-week high of Niagen Bioscience Inc?

The 52-week high of Niagen Bioscience Inc is 14.69.

What is the 52-week low of Niagen Bioscience Inc?

The 52-week low of Niagen Bioscience Inc is 4.16.

What is the market capitalization of Niagen Bioscience Inc?

The market capitalization of Niagen Bioscience Inc is 270.15M.

Is Niagen Bioscience Inc (NAGE) currently rated as Buy, Hold, or Sell?

According to analysts, Niagen Bioscience Inc (NAGE) has an overall rating of Buy, with a price target of 12.42.

What is the Earnings Per Share (EPS TTM) of Niagen Bioscience Inc (NAGE)?

The Earnings Per Share (EPS TTM) of Niagen Bioscience Inc (NAGE) is 0.22.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.